Ultragenyx Pharmaceutical News and Activities

Presence

Ultragenyx Pharmaceutical develops and sells medicines for rare genetic diseases. Its products and services include specialty therapies, clinical development, and patient support for people with rare conditions and healthcare providers.

Ultragenyx Pharmaceutical products and services overview:

Rare disease therapies
Gene therapy
Biologic medicines
Clinical development
Patient support

Revenue: ~$600 million

Employees: 1,400

Headquarters: Novato, Canada

Ultragenyx Pharmaceutical is one of the...

Ultragenyx Pharmaceutical is a company listed under the stock ticker RARE (US).

Executives

View the org chart displaying its 24 main executives

Most searched biographies at Ultragenyx Pharmaceutical

Popular executive movements at Ultragenyx Pharmaceutical

Antonis Koutsoukos, Vice President, Biometrics, has left the company (posted on May 8 2026).
Eric Olson has joined the company as Chief Business Officer (posted on October 1 2025).

Create your alert
to follow the executive moves at Ultragenyx Pharmaceutical.